Back to search

Peptide record

TPDB22976

Antibacterial Anticancer Toxicity standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB22976
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
standard
No
A 9-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
LLRWWWRLL
Physicochemical Analysis
C69H100N18O10
ANDCEQGHIKMFPSTYV
L
1341.67
12.40
2
0
7
+2
-6.17
0.389
173.33
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
16500
1229.81
0
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
4
L
0
K
0
M
0
F
0
P
0
S
0
T
3
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 4 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 3 Y: 0 V: 0
Chemical Descriptors
9
C69H100N18O10
1341.67
12.40
+2
-6.17
0.389
Evidence Records 2 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Novel Arginine End-Tagging Antimicrobial Peptides to Combat Multidrug-Resistant Bacteria | ACS Appl Mater Interfaces | 2022
Evidence 2 Activity

Activity

<10% Killing
Toxicity
64 µM
Cytotoxic
<10% Killing | 64 | µM | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Novel Arginine End-Tagging Antimicrobial Peptides to Combat Multidrug-Resistant Bacteria | ACS Appl Mater Interfaces | 2022